Sensei Biotherapeutics, Inc. - 8-K Filing
Sensei Biotherapeutics announced that Karen Vousden, Ph.D., will delay her board appointment until later in 2026 due to personal reasons; the Board plans to consider appointing Dr. Vousden in Q3 or Q4 of 2026 and intends to name Bob Holmen as chair of the Nominating and Corporate Governance Committee effective June 12, 2026 if stockholder matters are approved at its Annual Meeting on June 10. (Items: 8.01 Other Events)
Tickers: $SNSE